You are here

VRTX

$147.41

0.00%

Investor Relations

Analyst Coverage

Vertex Pharmaceuticals is covered by the following analysts.

Analyst Coverage
Firm Analyst
Baird
Brian Skorney
Bank of America Merrill Lynch
Ying Huang, Ph.D.
Barclays
Geoffrey Meacham, Ph.D.
BMO Capital Markets
Do Kim
BTIG
Dane Leone
Citi Research
Robyn Karnauskas, Ph.D.
Cowen & Co.
Phil Nadeau, Ph.D.
Credit Suisse
Alethia Young
Goldman Sachs
Terence Flynn, Ph.D.
Guggenheim Securities
Tony Butler, Ph.D.
HC Wainwright
Andrew Fein
J.P. Morgan
Cory W. Kasimov
Jefferies
Michael Yee
JMP Securities
Liisa Bayko
Leerink
Geoff Porges, Ph.D.
Maxim Group
Jason McCarthy
Morgan Stanley
Matthew Harrison
Needham & Company
Alan Carr, Ph.D.
Oppenheimer
Hartaj Singh
Piper Jaffray
Edward Tenthoff
Raymond James
Laura Chico
RBC
Brian Abrahams, M.D.
Stifel
Adam Walsh, M.D.
UBS Equities
Carter Gould
William Blair
Katherine Xu

Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.